MEDP Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio28.96Forward 27.25
EPS (TTM)$15.8816.6% YoY
Profit margin17.2%HEALTHCARE
Market cap$13.13BLarge cap
Wall Street coverage
$442.83median target· current $400.63 (+10.5%)13 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 27.25
- PEG ratio
- 2.81
- P/B
- 21.85
- P/S (TTM)
- 4.90
- EV/EBITDA
- 21.22
Profitability & growth
- ROE (TTM)
- 77.2%
- Operating margin
- 20.0%
- Revenue growth YoY
- 26.5%
- Dividend yield
- —
- Beta
- 1.18
Last earnings
Apr 22, 2026 · Estimate $3.96 · Reported $4.28
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Medpace Holdings Inc
Company profileMedpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.
Classification
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 5375 MEDPACE WAY, CINCINNATI, OH
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$13.13B
Shares outstanding$28.6M
52W high$628.92
52W low$301.90
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent